InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Colangelo Dominick, Chairman & CEO. Director active across 1 companies, notably Vericel Corp. Cumulatively, 4 disclosures have been published. The latest transaction was filed on 19 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
08,937 shares0
Common Stock
SEC:0001593968-22-000514:0·
07,500 shares0
Common Stock
SEC:0001593968-22-000468:0·
06,937 shares0
Common Stock
SEC:0001593968-22-000421·
06,937 shares0
Common Stock
SEC:0001593968-22-000421:0·
4 of 4 declarations
About Colangelo Dominick
Dominick Colangelo is the President and CEO of Vericel Corp, a company specializing in cell and gene therapies. Under his leadership, Vericel focuses on innovation and improving treatments for patients. His leadership is essential for the company's strategy and development.
